Company History Timeline — 2010s
Agilent purchases Varian, Inc., the largest acquisition to date in the company’s history. The majority of Varian’s product lines join Agilent’s Chemical Analysis Group (CAG), while the Life Sciences Group (LSG) gains key businesses, including nuclear magnetic resonance (NMR).
Agilent and the National Center for Food Safety and Technology (NCFST) enter into a collaboration to develop new scientific methods for analyzing food borne illnesses and food quality. As a part of this effort, Agilent provides NCFST with an extensive assortment of the latest analytical chemistry and life science instrumentation, along with training and applications support.
Agilent joins in a collaborative effort with the newly formed Synthetic Biology Institute at UC Berkeley as its first Industry Member.
China becomes the first country outside the United States to achieve over $1 billion in orders with Agilent during a single year.
Agilent's board of directors declares the first quarterly cash dividend in the company's history—10 cents per share.
Agilent joins forces with the University of California at Davis and the U.S. Food and Drug Administration to initiate the 100,000 Genome Project, a massive five-year effort to improve food safety. The project will harness cutting-edge technology to enable faster responses to foodborne outbreaks.
Dako, a cancer diagnostics company headquartered in Denmark, becomes the largest acquisition in Agilent’s history. The acquisition enables Agilent to grow its diagnostics business and expand its role in life sciences. About 1,000 Dako employees join Agilent. Agilent’s milestones for the Dako brand provides a view of historical information about it's Dako brand.
Agilent opens two offices in Hanoi and Ho Chi Minh City to provide customers in Vietnam with sales, applications and support services. As one of the fastest-developing business areas in the world, Vietnam is a critical part of Agilent's emerging markets strategy.
On Sept. 19, Agilent announces "the most profound change in its history," according to Chief Executive Officer Bill Sullivan. The company will separate into two industry-leading public companies, one comprising the life sciences, diagnostics and applied markets (LDA) businesses, which will retain the Agilent name, and the second consisting of the electronic measurement (EM) business. Sullivan will continue to head Agilent; Agilent President and Chief Operating Officer Ron Nersesian will become president and CEO of the new company, to be named.
Agilent announces its CEO transition plan in September 2014 with William P. (Bill) Sullivan’s retirement next year, naming Mike McMullen as CEO-elect for March 2015. As a first step in the transition, Mike is appointed president and chief operating officer, effective immediately. Bill will become an advisor in March until his retirement at the end of fiscal 2015.
Agilent completes the spinoff of its former electronic measurement business—Keysight Technologies—on Nov. 1. Keysight begins trading on the New York Stock Exchange on Nov. 3 under the symbol KEYS.
Mike McMullen is elected Agilent CEO by the board of directors, and on March 18, 2015, becomes the third president and CEO in the company’s history, replacing Bill Sullivan.